US FDA approves nasal spray for migraines
The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.
Mar 10, 2023
0
8
The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.
Mar 10, 2023
0
8
Approximately three million Americans suffer from opioid use disorder, and every year more than 80,000 Americans die from overdoses. Opioid drugs, such as heroin, fentanyl, oxycodone and morphine, activate opioid receptors. ...
Feb 18, 2023
0
5
A recent study published in the Journal of Dental Research (JDR) has compared the effectiveness of ten pharmacological interventions in order to develop guidelines for acute pain management after tooth extraction in adults.
Jan 30, 2023
0
2
A group of scientists say they've created a safer version of fentanyl that could potentially diminish the drug's addictive side effects, which have resulted in annual deaths of tens of thousands of people across the United ...
Jan 23, 2023
0
12
A study by Oregon State University College of Pharmacy researchers suggests that two anticonvulsants often prescribed for chronic pain are only "modestly effective" at pain management and can create an unfavorable risk/reward ...
Dec 19, 2022
0
27
People taking prescription opioids are more than twice as likely to be involved in a car accident than those who aren't, research has shown. In fact, between the early 1990s and early 2010s, as opioid use rose sharply in ...
Dec 2, 2022
1
6
The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections.
Dec 1, 2022
0
4
Faulty batches of generic lamotrigine tablets—an anti-convulsant drug commonly used for treating bipolar disorder and epilepsy—are being dispensed to patients in Australia. The compromised product is likely a result of ...
Nov 30, 2022
0
25
The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no sensitizing ...
Nov 16, 2022
0
47
The nation's top public health agency on Thursday softened its guidelines for U.S. doctors prescribing oxycodone and other opioid painkillers.
Nov 3, 2022
0
2